BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2855939&ei=knKaUpCMFoqw0AGZAw&usg=AFQjCNEwosKdTfMhR3B21GrTC2akqH93og
Biogen Idec Inc Raises FY 2013 Guidance
Monday, 28 Oct 2013 07:15am EDT
Biogen Idec Inc increased its fiscal 2013 guidance and expects revenue growth to be approximately 23% to 25%, Non-GAAP diluted EPS to be between $8.65 and $8.85 and GAAP diluted EPS to be between $7.50 and $7.70. The Company reported revenues of $5.5 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $6.8 billion and EPS of $8.62 for fiscal 2013.Â 
